Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
Wang B, Dong Y, Yu X, Li F, Wang J, Chen H, Niu Z, Song Y, Yuan Z, Tao Z | Front Oncol | 2022
High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study
Ryuno Y, Abe T, Iino M, Saito S, Aoshika T, Oota T, Igari M, Hirai R, Kumazaki Y, Kaira K, Kagamu H, Ishida H, Noda SE, Kato S | Radiat Oncol | 2022
PO-1315: CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer
Martina Mori, Roberta Tummineri, Simone Baroni, Michela Olivieri, Sara Broggi, Chiara Lucrezia Deantoni, Paola Mangili, Andrei Fodor, Antonella Del Vecchio, Claudio Antonio Fiorino, Nadia Gisella Di Muzio | ESTRO | 2022
PO-1261: Is SBRT an effective treatment in metastatic lung cancer with oligoprogressive disease?
Michele Aquilano, Mauro Loi, Lorenzo Livi, Joost Nuyttens | ESTRO | 2022
PO-1246: Lung SBRT after pneumonectomy
Angela Botticella, Antonin Levy, Olaf Mercier, Guillaume Auzac, Aicha Traore-Diallo, Maxime Frelaut, Pauline Pradere, Caroline Caramella, Ines Kasraoui, Benjamin Besse, David Planchard, Cécile Le Pechoux | ESTRO | 2022
An Interpretable Machine Learning Model for Predicting Overall Survival for Malignant Mesothelioma Patients Following Radiotherapy
Z Wang, V Li, X Qi | AAPM | 2022
Optimal Method of Radixact Treatment Planning for IROC Lung Phantom with Motion Table to Meet VALOR Protocol Constraints
S Klash, E Mcclelland, C Sobotka, S Corbett | AAPM | 2022